Development and Optimization of Microballoons Assisted Floating Tablets of Baclofen.

AAPS PharmSciTech

Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Elite Status and Centre of Excellence (Maharashtra), Deemed University, N.P. Marg, Matunga East, Mumbai, Maharashtra, 400019, India.

Published: November 2021

The objective of the present study was to develop microballoons aided gastro-retentive floating tablets of baclofen, a skeletal muscle relaxant with a low elimination half-life of ~ 3.5 h. Baclofen floating tablet was prepared to offer convenience by designing a tablet that would float in the stomach for a prolonged period and allow controlled drug release to enable once-a-day administration. Ethylcellulose microballoons (ECMBs) prepared by pseudo emulsion solvent diffusion method were employed as floating aid. The ECMBs were spherical with a size of 446.71 µm and a circularity index of 0.995. Buoyancy of 98.90 percent and good flowability reflected by an angle of repose of 23° suggested the feasibility of preparing floating tablets by direct compression. Directly compressed baclofen floating tablets comprised ECMBs, HPMC-K15M, and hydroxyl ethylcellulose as independent variables in the Box-Behnken design, however, performance characteristics of tablets such as in vitro drug release, floating lag time, and swelling index were selected as the dependent variables. Among the variables, ECMBs played a critical role in ensuring buoyancy. However, HPMC-K15M significantly influenced in vitro drug release. The optimized batch displayed Hickson-Crowell kinetics and exhibited a similar drug release profile as a marketed once-a-day formulation (f, 91.03). Furthermore, optimized tablets showed a swelling index of > 300, floating lag time < 3 s, and total floating time > 24 h. Microballoons assisted floating tablets exhibited great promise for assured gastric retention of tablets.

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12249-021-02139-yDOI Listing

Publication Analysis

Top Keywords

floating tablets
20
drug release
16
floating
9
microballoons assisted
8
assisted floating
8
tablets
8
tablets baclofen
8
baclofen floating
8
vitro drug
8
floating lag
8

Similar Publications

Release-modulating mechanism and comparative pharmacokinetics in beagle dogs of bethanechol-loaded oral dosage forms.

Int J Pharm

January 2025

Department of Pharmacy, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea; Institute of Pharmaceutical Science and Technology, Ajou University, Suwon 16499, Republic of Korea. Electronic address:

Bethanechol chloride (BTC), a quaternary ammonium compound used in bladder dysfunction treatment, requires challenges in developing optimal oral dosage forms due to its high water-solubility, short half-life, rapid elimination and four times a day administration. The aim of this study was to develop optimal BTC-loaded oral dosage forms that could provide both rapid onset and sustained therapeutic effects while reducing the frequency of conventional four-times-daily dosing (Mytonin® tablets). Four different BTC-loaded oral dosage forms were designed including gastro-retentive tablet (GRT), controlled-release tablet (CRT), bilayer tablet (BLT), and tablet-in-tablet (TIT).

View Article and Find Full Text PDF
Article Synopsis
  • Large household water storage containers are key breeding sites for Aedes aegypti mosquitoes, which spread diseases like dengue.
  • Concerns over insecticide resistance and safety are challenging effective mosquito control, leading researchers to explore RNAi-based yeast larvicides as a solution.
  • A study developed a shelf-stable, controlled-release yeast formulation that shows promise for lasting mosquito control, demonstrating effectiveness in various container sizes and remaining active for up to six months.
View Article and Find Full Text PDF

Gastro retentive drug delivery systems (GRDDS) have gained immense popularity as they reduce dosing frequency, improve bioavailability, and enhance patient compliance. Herein, a plant-based, controlled swelling, and pH-sensitive GRDDS based on Aloe vera hydrogel and cellulose was developed for the sustained release of levofloxacin (LEVO). The properties of five various floating tablet formulations including dynamic swelling, pH-responsiveness, hardness, friability, drug release, and buoyant time were evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • Natural polysaccharides, like xanthan gum, are non-toxic, biocompatible, biodegradable, and bioadhesive, making them valuable in dietary, medicinal, biomedical, and cosmetic applications.
  • Xanthan gum is a naturally derived polysaccharide from Xanthomonas Campestris, known for its high molecular weight and versatility in various formulations, including tablets and nanoparticles.
  • The review highlights xanthan gum's potential in drug delivery systems, particularly gastroretentive systems, and discusses recent innovations and patents related to its floating techniques and modifications.
View Article and Find Full Text PDF
Article Synopsis
  • Gastric acid-related disorders like peptic ulcers and gastroesophageal reflux disease (GERD) are primarily caused by excessive stomach acid or bacterial infections, and can be treated with medications such as proton pump inhibitors (PPIs) and vonoprazan.
  • While PPIs work by irreversibly blocking the proton pump in stomach cells, vonoprazan inhibits acid secretion by targeting the potassium-competitive acid blocker receptor, making it one of the most effective options for GERD.
  • The review highlights various innovative micro/nano formulations of these medications, as well as the crucial role of imaging techniques like CT scans and endoscopy in diagnosing and managing these gastric acid disorders.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!